Balchem (BCPC) Stock Price, News & Analysis

Company Overview

Balchem Corporation is a global specialty chemicals and ingredient manufacturer headquartered in New Hampton, New York. Since its founding in 1960, the company has developed a reputation for providing innovative solutions across a range of markets, including human and animal nutrition, food and beverage, pharmaceutical and industrial applications. Balchem’s expertise in microencapsulation, powder and liquid formulations, and specialty actives enables it to deliver performance-driven ingredients that meet stringent quality and regulatory standards.

The company’s product portfolio spans key categories such as choline chloride and other specialty nutrients for animal feed; nutrient delivery systems and taste-masking ingredients for dietary supplements and pharmaceutical applications; and specialty carriers, release agents and processing aids for industrial uses. Balchem’s microencapsulation technology allows for controlled release, flavor protection and enhanced stability, while its industrial product lines support applications ranging from metal packaging to odor management and asphalt modification.

With a presence in North America, Europe, Asia Pacific and Latin America, Balchem operates multiple manufacturing sites, research and development centers and technical support offices around the world. This global network enables the company to collaborate closely with customers on tailor-made solutions, ensure timely supply, and adapt to regional regulatory requirements. Balchem’s commitment to innovation is bolstered by ongoing investment in R&D and strategic partnerships within the specialty chemicals industry.

Under the leadership of President and Chief Executive Officer Kurt P. Smith, Balchem continues to expand its product offerings and geographic reach while maintaining a focus on sustainability, quality management and operational excellence. The company’s long track record of growth is driven by its ability to anticipate market trends, deliver high-value ingredient solutions and support customers in achieving their own performance and regulatory objectives.

Key Stats

• Today's Range: $162.63 to $165.13
• 50-Day Range: $153.64 to $170.45
• 52-Week Range: $145.70 to $186.03
• Volume: 83,019 shs
• Average Volume: 142,903 shs
• Market Capitalization: $5.38 billion
• P/E Ratio: 39.55
• Dividend Yield: 0.53%
• Price Target: $180.00
• Consensus Rating: Moderate Buy

Balchem Stock Analysis - MarketRank™

Balchem scored higher than 82% of companies evaluated by MarketBeat, and ranked 145th out of 576 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Balchem has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Balchem has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 10.99%

Earnings Growth

Earnings for Balchem are expected to grow by 10.99% in the coming year, from $4.64 to $5.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Balchem is 39.55, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.53.

Price to Earnings Ratio vs. Sector

The P/E ratio of Balchem is 39.55, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 94.43.

Price to Earnings Growth Ratio

Balchem has a PEG Ratio of 3.52. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Balchem has a P/B Ratio of 4.66. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.45% of the float of Balchem has been sold short.

Short Interest Ratio / Days to Cover

Balchem has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Balchem has recently decreased by 9.94%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Balchem has a dividend yield of 0.53%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Balchem has been increasing its dividend for 16 years.

Dividend Coverage

The dividend payout ratio of Balchem is 20.86%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Balchem will have a dividend payout ratio of 16.89% next year. This indicates that Balchem will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 2.3 / 5
• Environmental Score: -1.54

Percentage of Shares Shorted

1.45% of the float of Balchem has been sold short.

Short Interest Ratio / Days to Cover

Balchem has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Balchem has recently decreased by 9.94%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.75

News Sentiment

Balchem has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Basic Materials companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Balchem this week, compared to 5 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Balchem insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.39% of the stock of Balchem is held by insiders.

Percentage Held by Institutions

87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

BCPC Stock Analysis - Frequently Asked Questions

How have BCPC shares performed this year?

Balchem's stock was trading at $162.99 at the start of the year. Since then, BCPC stock has increased by 1.2% and is now trading at $164.9150.

How were Balchem's earnings last quarter?

Balchem Corporation (NASDAQ:BCPC) released its earnings results on Thursday, April, 24th. The basic materials company reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.25 by $0.03. The firm's revenue for the quarter was up 4.5% on a year-over-year basis.
Read the conference call transcript.

Does Balchem have any subsidiaries?

The following companies are subsidiaries of Balchem: Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and others.

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 4/24/2025
• Today: 7/03/2025
• Next Earnings (Estimated): 7/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Basic Materials
• Industry: CHEM - SPECIALTY
• Sub-Industry: Specialty Chemicals
• Current Symbol: NASDAQ:BCPC
• CIK: 9326
• Web: www.balchem.com
• Phone: (845) 326-5600
• Fax: 845-326-5717
• Employees: 1,361
• Year Founded: 1967

Price Target and Rating

• Average Stock Price Target: $180.00
• High Stock Price Target: $180.00
• Low Stock Price Target: $180.00
• Potential Upside/Downside: +9.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.17
• Trailing P/E Ratio: 39.55
• Forward P/E Ratio: 35.54
• P/E Growth: 3.49
• Net Income: $128.48 million
• Net Margins: 14.16%
• Pretax Margin: 18.41%
• Return on Equity: 12.01%
• Return on Assets: 8.77%

Debt

• Debt-to-Equity Ratio: 0.18
• Current Ratio: 2.44
• Quick Ratio: 1.40

Sales & Book Value

• Annual Sales: $953.68 million
• Price / Sales: 5.64
• Cash Flow: $5.53 per share
• Price / Cash Flow: 29.82
• Book Value: $35.37 per share
• Price / Book: 4.66

Miscellaneous

• Outstanding Shares: 32,620,000
• Free Float: 32,164,000
• Market Cap: $5.38 billion
• Optionable: Optionable
• Beta: 0.89